These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4973842)

  • 1. [Retroaction effect of certain pyrazolopyrimidines on the metabolism of uric acid].
    Delbarre MF; Auscher C; Kha-Vang-Thang ; Brouilhet H; de Gery A
    C R Acad Hebd Seances Acad Sci D; 1968 Dec; 267(25):2231-4. PubMed ID: 4973842
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clearance of oxypurines in normal subjects and in gout patients subjected to a purine-free diet. Effects of allopurinol].
    Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
    Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1105-10. PubMed ID: 2629828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of gouty purine metabolism disorder with mercapto-pyrazolo-pyrimidine (thiopurinol)].
    Delbarre F; Auscher C; de Gery A; Brouilhet H; Olivier JL
    Presse Med (1893); 1968 Dec; 76(49):2329. PubMed ID: 5737251
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi.
    Emmerson BT
    Australas Ann Med; 1967 Aug; 16(3):205-14. PubMed ID: 6056609
    [No Abstract]   [Full Text] [Related]  

  • 5. Xanthine oxidase deficiency: studies of a previously unreported case.
    Holmes EW; Mason DH; Goldstein LI; Blount RE; Kelley WN
    Clin Chem; 1974 Aug; 20(8):1076-9. PubMed ID: 4369449
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.
    Chalmers RA; Krömer H; Scott JT; Watts RW
    Clin Sci; 1968 Oct; 35(2):353-62. PubMed ID: 5721238
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic studies of allopurinol, an inhibitor of xanthine oxidase.
    Elion GB; Kovensky A; Hitchings GH
    Biochem Pharmacol; 1966 Jul; 15(7):863-80. PubMed ID: 5967902
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of uric acid formation.
    N Engl J Med; 1968 Feb; 278(6):331-2. PubMed ID: 5638350
    [No Abstract]   [Full Text] [Related]  

  • 9. Allopurinol: alteration in pyrimidine metabolism in man.
    Kelley WN; Beardmore TD
    Science; 1970 Jul; 169(3943):388-90. PubMed ID: 5450375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations of tissue oxypurine levels with xanthine dehydrogenase changes in the chick.
    DeLapp NW; Fisher JR
    Biochim Biophys Acta; 1972 May; 269(3):505-14. PubMed ID: 5039546
    [No Abstract]   [Full Text] [Related]  

  • 11. [Modalities of purine excretion during enzyme treatment of gout and other hyperuricemic conditions with urate oxidase].
    Royer R; Vindel J; Lamarche M; Kissel P
    Presse Med (1893); 1968 Dec; 76(49):2325-7. PubMed ID: 5737250
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical evidence for a distinct type of primary gout.
    Sorensen LB; Benke PJ
    Nature; 1967 Mar; 213(5081):1122-3. PubMed ID: 6029792
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees.
    Komoriya K; Osada Y; Hasegawa M; Horiuchi H; Kondo S; Couch RC; Griffin TB
    Eur J Pharmacol; 1993 Dec; 250(3):455-60. PubMed ID: 8112406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The level of oxypurines in the plasma and urine of control and gout patients. (Correlation with the level of uric acid)].
    Auscher C; Brouilhet H; Delbarre F
    Sem Hop; 1967 Apr; 43(17):1123-6. PubMed ID: 4293530
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analysis of uric acid and oxypurines in normal subjects and in gout patients].
    Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
    Boll Soc Ital Biol Sper; 1989 Dec; 65(12):1201-5. PubMed ID: 2627336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative study of skeletal-muscle purines and pyrazolo(3,4-d)pyrimidines in gout patients treated with allopurinol.
    Watts RW; Snedden W; Parker RA
    Clin Sci; 1971 Aug; 41(2):153-8. PubMed ID: 5564305
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of plasma and urine purines, after a purine-free diet, in normal subjects and patients with gout].
    Vannoni D; Porcelli B; Di Stefano A; Pizzichini M; Leoncini R; Terzuoli L; Taddeo A; Marsini S; Morozzi G; Marcolongo R
    Medicina (Firenze); 1989; 9(3):295-7. PubMed ID: 2615605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopurinol in patients with impaired renal function.
    Levin NW; Abrahams OL
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):681-7. PubMed ID: 5958698
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current biochemical acquisitions on pathogenesis of gout].
    Marcolongo R
    Reumatismo; 1971; 23(3):109-25. PubMed ID: 5150688
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of allopurinol on the metabolism of uric acid].
    Swiderska-Kulikowa B; Jelińska S
    Pol Arch Med Wewn; 1973 Apr; 50(4):391-8. PubMed ID: 4574007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.